THE GLITCH#

Chapter Three#

DAVID SHAW: The Director of Wellness#

The Telexa campus was a triumph of intentional architecture — glass, reclaimed teak, and living moss walls designed to lower cortisol levels while reminding you that you were never supposed to leave, the two goals being not as contradictory as they sounded. David’s office was on the fourth floor of Building 12, a space specifically “calibrated” for deep focus, which meant the lighting changed spectrum every two hours to mimic the natural progression of the sun. It was supposed to prevent the very burnout David felt in his marrow, which meant the office was, in some technical sense, doing something to him even as it failed to do the right thing.

He sat in his $2,400 Aeron chair, the mesh supporting his spine with a precision that his United Healthcare policy apparently considered “recreational.” The chair was excellent. The chair was, without question, the best chair he had ever owned. It had not solved anything, which was the trajectory most expensive solutions took if you followed them long enough.

His morning had been a blur of “synching” and “level-setting” — the vocabulary of coordination meetings that had migrated, over the past decade, from describing something into simply being something, the words themselves doing the work previously done by thinking. He had moderated three separate Slack threads about the ethical implications of Telexa’s new AI-driven “Sleep-Coach” potentially misidentifying sleep apnea in low-income demographics. It was a classic Telexa problem: they had optimized the algorithm for high-performance users in the Bay Area, and now it was telling a warehouse worker in Ohio that his life-threatening snoring was just “sub-optimal recovery.” The algorithm had not been wrong about Bay Area users. It had been right about a population that did not include the warehouse worker in Ohio, which was a different thing, and the difference was the meeting.

David rubbed his temples.

“Dr. Shaw? You have your 10:30. Dr. Arispe from United,” his assistant’s voice crackled through the intercom. “It’s a peer-to-peer for the L5-S1 PT appeal.”

David straightened his back, the bright wire in his leg vibrating in protest. “Put him through, Sarah.”

He clicked his headset. He had his talking points ready. He’d reviewed the clinical guidelines from the American Academy of Orthopaedic Surgeons — had, in fact, reviewed them the way he used to review charts before rounds, thoroughly, with the particular attention of someone who expects to be challenged. He had his own MRI on the second monitor, the disc protrusion at L5-S1 looking like a small, angry thumb pressing into the dark canal of his nerve root.

“This is Dr. Arispe,” a voice said. It was thin and hurried, the sound of a man who was paid by the denial.

“Dr. Arispe, David Shaw here. I’m calling regarding the denial of authorization for the physical therapy sessions for patient—well, for the patient in question.”

“Right. The appeal for the ten sessions. The algorithm flagged the request as outside the standard recovery trajectory for this age bracket and clinical presentation.”

“The algorithm is using a generalized mean that doesn’t account for the degree of sequestration shown on the MRI,” David said, dropping into the calm, authoritative register he’d been using with insurance reviewers for fifteen years — the voice that said I am a colleague engaging you professionally, the voice that said please do not make me say the next voice out loud. “The patient is experiencing significant neurological deficit — specifically, foot drop and diminished reflex in the left Achilles. Conservative management via PT is the only step remaining before we’re looking at a $40,000 microdiscectomy. United would surely prefer the $2,000 for PT over the surgical intervention.”

There was a pause. David could hear the clicking of a keyboard on the other end.

“I see your point, Dr. Shaw,” Arispe said. “The clinical justification is sound. The MRI data does indeed suggest a more aggressive conservative approach is warranted. Honestly, it’s refreshing to speak with someone who actually knows the ICD-10 codes.”

“I appreciate that, Dr. Arispe. So, we’ll move to approved status?”

“I was just about to hit the override,” Arispe said. “But — Dr. Shaw, I’m looking at the patient ID here. And I’m looking at the provider ID for the appealing physician.”

David’s stomach did a slow, cold roll — the specific gastrointestinal sensation of a person watching a punchline arrive that they have been too clever to see coming.

“Is there a problem?”

“The patient is David Shaw,” Arispe said. The hurried tone was gone, replaced by something flatter, more legalistic — the voice that came out when the script had a specific section for this. “And the appealing physician is Dr. David Shaw.”

“I am a board-certified physician with fifteen years of clinical experience in this exact field,” David said, his voice tightening with the particular tightness of a man who has just watched a technically correct argument collide with a procedurally bulletproof wall. “The clinical facts don’t change because the patient and the doctor share a Social Security number.”

“Under the terms and conditions of the United Healthcare provider agreement, specifically Section 4.2 regarding conflict of interest, a physician may not represent themselves in a peer-to-peer appeal. The appeal is denied on procedural grounds. The clinical merits are irrelevant once the procedural violation is identified.”

“Procedural? I just laid out a path that saves your company thirty thousand dollars and preserves a man’s ability to walk without a cane.”

“The algorithm is designed to ensure procedural integrity, Dr. Shaw. If we allow self-representation, the entire peer-review system loses its objective validity.”

“Objective validity? You’re reading from a script written by a bot to ensure you don’t have to pay for a treadmill and some resistance bands.”

“Appeal denied,” Arispe said. “Have a healthy day, Dr. Shaw.”

The line went dead.

David sat in the calibrated silence of his office — the light exactly at the spectrum the system had determined was appropriate for mid-morning productivity, the temperature precisely at the setting that data suggested supported focused work, the chair perfectly adjusted for a man of his height and lumbar profile. On his monitor, the disc still pressed into the nerve, exactly as it had been pressing since this conversation began. The system had recognized him as a procedural error. It had not been wrong about that, in any technical sense he could identify.

He looked at his watch. 10:42 AM.

He had another meeting in three minutes to discuss the “moral imperative” of Telexa’s sleep metrics. He stood up, the pain in his leg screaming with the consistency of something that had learned it could not be argued with, and realized he was going to have to buy the resistance bands on Amazon.

The Aeron chair cost $2,400. The resistance bands would cost eleven dollars. He was the Director of Sleep Wellness at one of the largest tech companies on earth.

He found his jacket and went to his next meeting.

(End of Chapter Three)